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Abstract
Background: Hundreds of thousands of volunteers take part in medical research, but many will never hear from
researchers about what the study revealed. There is a growing demand for the results of randomised trials to be
fed back to research participants both for ethical research practice and for ensuring their co-operation in a trial.
This study aims to determine participants’ preferences for type of leaflet (short versus long) used to summarise the
findings of a randomised trial; and to test whether certain characteristics explained participants’ preferences.
Methods: 553 participants in a randomised trial about General Practitioners’ access to Magnetic Resonance
Imaging for patients presenting with suspected internal derangement of the knee were asked in the final follow-up
questionnaire whether they would like to be fed back the results of the trial. Participants who agreed to this were
included in a postal questionnaire survey asking about their preference, if any, between a short and a long leaflet
and what it was about the leaflet that they preferred. Multinomial logistic regression was used to test whether
certain demographics of responding participants along with treatment group explained whether a participant had
a preference for type of leaflet or no preference.
Results: Of the participants who returned the final follow-up questionnaire, 416 (88%) agreed to receive the results
of the trial. Subsequently 132 (32%) participants responded to the survey. Most participants preferred the longer
leaflet (55%) and the main reasons for this were the use of technical information (94%) and diagrams (89%). There
was weak evidence to suggest that gender might explain whether participants have a preference for type of leaflet
or not (P = 0.084).
Conclusions: Trial participants want to receive feed back about the results and appear to prefer a longer leaflet.
Males and females might require information to be communicated to them differently and should be the focus of
further research.
Trial registration: The trial is registered with http://www.isrctn.org/ and ID is ISRCTN76616358.
Background
Every year hundreds of thousands of volunteers take part
in medical research, but many will never hear from
researchers about what the study revealed. There is now
a growing demand for the results of randomised trials to
be fed back to research participants [1,2]. Feeding back
the results of trials has been described as an element of
ethical research practice [3] and is a recommendation of
the United Kingdom Department of Health’s research
governance framework [4]. This has also been described
as a participant’s right and that achieving their full co-
operation in designing, conducting, reporting and imple-
menting the results of research may ensure that they are
the first people to hear the results [2]. Furthermore the
majority of research participants want this right [5,6].
The results of trials, however, can be complicated,
alarming and distressing [7]. The perceived negative psy-
chological consequences of providing feedback may pre-
sent a barrier to communicating study results [3,8].
Studies have shown that negative psychological reactions
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upset; although these studies also report participants
being relieved or satisfied to receive trial results even if
there is a potentially negative impact [7,9,10]. Despite the
recent calls for research to be disseminated to partici-
pants and the potential for negative psychological impact
there is currently little evidence advocating the most
effective approach of communicating results - the pre-
paration of such materials can be costly and time con-
suming [3,5].
In the DAMASK trial, we undertook a multi-centre
pragmatic randomised trial to address the question of
whether patients presenting to General Practitioners
(GPs) with suspected internal derangement of the knee
should be referred for early access to Magnetic Reso-
nance Imaging (MRI) or directly to an orthopaedic spe-
cialist [11-13]. In view of the paucity of evidence to
inform the method of communicating results to trial par-
ticipants we thought it was timely to explore how partici-
pants might prefer to be fed back the results of a trial.
The objectives of our survey w e r e :t od e t e r m i n ep a r t i c i -
pants’ preferences, if any, for type of leaflet (short versus
long) which summarise thef i n d i n g so ft h eD A M A S K
trial; and to test whether certain demographics (e.g. gen-
der, age) and treatment group explained whether the par-
ticipants had a preference for type of leaflet or not.
Methods
Research Design
In the final follow-up questionnaire we asked the 553
participants in the DAMASK trial whether they would
like to receive the results of the study. Participants who
requested feedback of study results were then included in
our survey after the results of the trial had been pub-
lished in scientific journals [11-13]. This included being
sent a cover letter asking the participants to take part in
the survey, two leaflets (short and long) summarising the
trial findings, and a one-page questionnaire. The short
leaflet was a one-page summary in the style of an abstract
that was written in plain language using bullet points,
with minimum use of numbers, and no pictures or dia-
grams. The structure of this leaflet was presented as:
background; aims of the study; how we did it; what we
found; and conclusion. The longer leaflet was four pages
in length which included a picture of MRI of the knee
and two diagrams (a pie chart and bar chart) presenting
results of the trial. The content of the leaflet was more
technical with far greater use of numbers and percen-
tages and explained the main results in terms of con-
fidence intervals. The structure of this leaflet was
presented as: background; aims of the study; how we did
it; data collected; what we found; and should GP access
to MRI of the knee be introduced into the NHS? Contact
details of the trial co-ordinator were included at the end
of each leaflet, copies of which are available on request
from the corresponding author. Participants were asked
t oc o m p l e t eao n e - p a g eq u e stionnaire about whether
they preferred the one-page leaflet, the four-page leaflet
or had no preference. If a participant preferred a type of
leaflet they were asked (yes/no) whether it was due to: its
length; the amount of technical information; the use
of numbers; the use of percentages; the use of diagrams.
A free text box was provided for participants to record
other reasons about their preference for a leaflet.
Analysis
To test for differences in baseline characteristics of parti-
cipants who did and did not respond to completing the
survey we used c
2 tests and t-tests. Participants’ prefer-
ence for a type of leaflet or no preference and the reason
for their preference are presented descriptively. Addi-
tional free text responses as to why participants preferred
a type of leaflet were coded retrospectively. Multinomial
logistic regression was usedt ot e s tw h e t h e rc e r t a i n
demographics of responding participants (i.e. gender [0 =
female; 1 = male]; age [years], employment [0 =
employed; 1 = other], age left education [years]) along
with treatment group [0 = MRI (and Orthopaedic Refer-
ral); 1 = Orthopaedic Referral] explained their preference
for a type of leaflet or not. This analysis was undertaken
using Stata version 10.0 (Statacorp, Texas) [14] and
included the commands mlogit and mlogtest [15].
Research ethics
The DAMASK trial was designed to comply with the
Declaration of Helsinki as adopted by the World Medical
Association. The Northern and Yorkshire Multi-Centre
Research Ethics Committee approved the trial (reference
number MREC/1/3/59). Ethics approval was not neces-
s a r yf o rt h i ss u r v e ya sw ew e r ea d v i s e dt h a tt h i sw a sa n
audit of feeding back trial results to participants.
Results
Of the 553 participants in the DAMASK trial, 471 (85%)
completed the final follow-up questionnaire. For those
participants who returned the final follow-up question-
naire, 416 (88%) agreed that they would like to receive
the results of the study. Subsequently 132 (32%) partici-
pants responded to the survey about their preference for
type of leaflet feeding back the results of the trial. Of
these 132 participants, 73 (55%) were in the MRI (and
orthopaedic referral) group and 59 (45%) were in the
orthopaedic referral (control group).
Table 1 presents the baseline characteristics of partici-
pants who did and did not complete the questionnaire.
Responders and non-responders were similar in key
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tional functioning sub-scale of the KQoL-26 question-
naire (P = 0.019).
Table 2 presents participants’ preferences for the one-
page leaflet, four-page leaflet or no preference for a leaflet.
Most participants preferred the four-page leaflet (55%).
The main reasons for preferring this leaflet was use of
technical information (94%) and diagrams (89%). Of the
73 participants who preferred the four-page leaflet, 31
(44%) recorded reasons in free text as to why they pre-
ferred this leaflet. This re-iterated the use of diagrams as a
good visual aid and the provision of more detailed
information which improved understanding. Only 21% of
participants preferred the one-page who all recorded this
was because of the length of the leaflet (100%); and 15
(54%) of them also recorded that their reason for choosing
this leaflet was its shortness and simplicity although some
suggested that it would benefit from the use of diagrams.
Table 3 presents the results of the regression analysis
that explored the effect of participant characteristics and
treatment group on their preference for type of leaflet
or no preference. The pseudo R
2 shows that only 4% of
variation was explained by this model, though with ade-
quate goodness-of-fit. None of the variables significantly
Table 1 Participants’ characteristics at baseline
Characteristics Responders (n = 132) Non-responders (n = 284) P-Values
Sex: male, n (%) 78/132 (59.1) 177/284 (62.3) 0.529
Ethnicity: white, n (%) 127/129 (98.4) 274/277 (98.9) 0.691
Employed: yes, n (%) 112/126 (88.9) 240/261 (92.0) 0.325
Age, years
n 132 284 <0.001
Mean (SD) 43.0 (9.4) 39.2 (10.3)
KQoL-26 (0-100, 100 = best health):
Physical functioning
N 131 283 0.962
Mean (SD) 59.3 (19.4) 59.2 (19.2)
Activity limitations
N 130 283 0.374
Mean (SD) 52.9 (25.1) 50.5 (25.2)
Emotional functioning
N 131 284 0.019
Mean (SD) 45.7 (22.1) 40.4 (21.1)
SF-36 (mean = 50, SD = 10, 100 = best health):
a
Physical component
N 129 267 0.088
Mean (SD) 40.0 (8.3) 38.4 (8.8)
Mental component
N 129 267 0.388
Mean (SD) 49.1 (10.9) 48.0 (11.4)
EQ-5D (0-1, 1 = best health)
N 131 283 0.064
Mean (SD) 0.62 (0.23) 0.57 (0.27)
a The SF-36 physical and mental health summary scales use norm-based scoring; 50 (SD = 10) is the general United States population mean
Table 2 Participants’ preference for type of leaflet or no preference
Reason for preference No preference n (%) One-page leaflet n (%) Four-page leaflet n (%) Total n
Overall preference 31/132 (24) 28/132 (21) 73/132 (55) 132
a) Length 1/8 (12) 28/28 (100) 26/65 (40) 101
b) Technical information 5/8 (62) 9/25 (36) 64/68 (94) 101
c) Use of numbers 3/8 (37) 8/26 (31) 37/64 (58) 98
d) Use of percentages 4/8 (50) 6/26 (23) 47/66 (71) 100
e) Use of diagrams 5/8 (62) 2/26 (8) 63/71 (89) 105
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between ‘no preference for a leaflet and the four-page
leaflet’ and the ‘one-page leaflet and the four-page leaf-
let’. The final comparison between the ‘one-page leaflet
and having no preference for a leaflet’ did find that
males compared to females were significantly less likely
to prefer the one-page leaflet, Odds ratio (OR) = 0.263
(95% CI 0.079 to 0.880), P = 0.030.
Table 4 shows the results of the likelihood tests of the
contribution of each independent variable to the regres-
sion model with only gender approaching a significant
effect on preference for type of leaflet or no preference
(c
2 = 4.96, df = 2, P = 0.084).
Discussion
Most participants (88%) wanted feed back of the
DAMASK trial results which is comparable with find-
ings from a literature review that a median of 90%
(range 20%-100%) of participants wished to receive
study results [5]. This range of patients wanting feed-
back is, however, very wide. Interestingly the review
showed that for several studies of patients being treated
for cancer, 90% of participants or more wanted to be
informed of the study results [16-19]. In contrast, for
studies of pregnant women only 20% [10] and 40% [20]
of woman wanted study results. In our trial we asked
participants about being fed back the study results at
the final postal questionnaire follow-up, but it might be
more appropriate to do this when enrolling patients to
take part and include it in the patient information leaflet
and consent of patients.
The majority of participants (55%) preferred the longer
leaflet and the main reasons for this were the technical
information provided and use of diagrams to explain trial
results. In contrast, every participant who preferred the
one-page leaflet gave length of the leaflet as the reason
for this. In the free text responses it was clarified that the
leaflet being short and simple was the reason for prefer-
ring the one-page leaflet although some suggested the
leaflet would have benefited from the use of diagrams.
Graphical formats are increasingly being used to present
risk information to patients [21,22] and has been shown
to improve their understandingo fq u a n t i t a t i v ei n f o r m a -
tion over textual or written formats [23,24]. Our findings
support the use of a longer leaflet with visual aids to
explain trial results which in particular might benefit par-
ticipants with reading difficulties or low numeracy skills.
Table 3 Multinomial logistic regression model for variables that explain participants’ preference
Participant preference Coefficient, B Standard Error P-Value Exp(B) 95% CI for Exp(B)
No preference Vs Four-page
Gender 0.656 0.518 0.205 1.927 0.698 to 5.317
Age 0.013 0.027 0.620 1.013 0.962 to 1.068
Education -0.111 0.086 0.199 0.895 0.756 to 1.060
Employed 0.090 0.700 0.897 1.094 0.277 to 4.320
Treatment 0.080 0.460 0.862 1.083 0.440 to 2.666
Constant 0.013 2.101 0.995 1.013 0.016 to 62.231
One-page Vs Four-page
Gender -0.679 0.492 0.168 0.507 0.193 to 1.330
Age 0.027 0.027 0.317 1.027 0.974 to 1.084
Education 0.015 0.069 0.828 1.015 0.887 to 1.162
Employed -0.686 0.866 0.428 0.504 0.092 to 2.748
Treatment -0.396 0.490 0.419 0.673 0.257 to 1.759
Constant -1.833 1.853 0.323 0.160 0.004 to 6.040
One-page vs No preference
Gender -1.335 0.616 0.030 0.263 0.079 to 0.880
Age 0.014 0.033 0.674 1.014 0.950 to 1.083
Education 0.126 0.098 0.199 1.134 0.516 to 1.373
Employed -0.776 0.977 0.427 0.460 0.068 to 3.126
Treatment -0.476 0.579 0.411 0.621 0.200 to 1.933
Constant -1.846 2.476 0.456 0.158 0.001 to 20.230
Log likelihood = -115.5; number of observations = 121; likelihood ratio c
2-test statistic, 9.9 df = 10 (P = 0.445); pseudo R
2 = 0.041
Table 4 Likelihood ratio tests for independent variables
Participant preference Chi-square df P-value
Gender 4.961 2 0.084
Age 1.101 2 0.577
Education 2.283 2 0.319
Employed 0.816 2 0.665
Treatment 0.823 2 0.663
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for a one-page leaflet compared with a four-page leaflet.
It is possible that a shorter leaflet such as two-pages with
the use of diagrams would have been preferred.
The findings from the regression analyses suggest that
gender can significantly influence preference for type of
leaflet (one-page) or no preference (P = 0.030); although
this was the only significant finding from the several expla-
natory analyses that were performed and thus possibly a
false-positive result that should be interpreted with cau-
tion. Whilst taking this into consideration: 71% of partici-
pants who had no preference for a leaflet were male (29%
female); 50% and 58% of males respectively preferred a
one-page or four-page leaflet. These findings indicate that
females were more interested in how the information
about trial results was presented to them which is consis-
tent with women using health services more than men
and seeking more health information [25]. Therefore it
might be appropriate in research that has a female popula-
tion such as treatments for breast cancer or during preg-
nancy to consider feeding back results differently than for
research including males such as the treatment for pros-
tate cancer. Research about communicating results to par-
ticipants of a cardiac rehabilitation trial has shown that
gender can be important with women (97%) compared to
men (76%) significantly more likely to prefer receiving
study results by letter (P = 0.009); and no women (0%)
compared to men (15%) preferring communication by
email or the web (P = 0.024) [26]. The use of qualitative
methods could help to further explore the communication
of trial results to males and females. None of the other
characteristics of the participants appeared to be impor-
tant for influencing their preference for a type of leaflet or
not. Including ethnicity as a variable in the analyses would
have been desirable, but in our survey sample there were
only two participants who were non-white (who both pre-
ferred the four-page leaflet). Therefore, it was not appro-
priate to include ethnicity in the model.
A limitation of our survey was the low response rate,
although participants’ characteristics were mostly similar
between those who did and did not respond. Younger
patients, however, were significantly less likely to
respond, though there was only a small difference in
years and, from the analyses, age was not important for
explaining participants’ preferences. Participants who
scored lower on the emotional functioning sub-scale of
the KQoL-26 questionnaire were also significantly less
likely to respond. This might possibly be a chance finding
although the emotional functioning sub-scale is con-
cerned with participants feeling downhearted and low,
angry and annoyed, or worried about their knee worsen-
ing. The trial findings indicated to participants that there
were only small benefits from GP access to MRI in terms
of the physical functioning of their knee. It is conceivable
that participants who were downhearted and low or
worried about their knee were dissatisfied with the lim-
ited benefits of the intervention and therefore were less
willing to complete the survey. Alternatively, they could
have been dissatisfied with the methods offered for feed-
ing back the trial results. Research into communicating
clinical trial results to participants in a study about Hun-
tington’s disease found that participants reported high or
complete satisfaction with an investigator of the trial con-
tacting individual participants by telephone to explain the
results (89%) or participants’ attendance to a conference
call with study investigators (82%) but relatively low satis-
faction with the sponsor’s press release (50%) [27]. It is
possible that the participants did not respond to our sur-
vey because they valued more personalised approaches to
communicating the trial results. There was also a consid-
erable delay from December 2006 which was when the
last participant was followed-up in the trial to May 2009
when we informed the participants of the results of the
trial. This was because we wanted to communicate the
most accurate results possible to participants that had
been peer-reviewed and accepted for publication in
scientific journals. This delay might have contributed to
participants’ lack of interest in the survey.
Despite several studies commenting on the negative psy-
chological impact of feeding back results of trials to parti-
cipants [7,9,10], the trial co-ordinator has not had any
contact with participants about the trial results. Nor did
p a r t i c i p a n t si nt h es u r v e ye x p r e s sa n ya n x i e t i e sa b o u t
the information conveyed. This may partly be due to the
limited generalisability of this study, in that it is a single
randomised trial including participants with a musculoske-
letal condition which was not particularly acute or life-
threatening and for which there was minimal difference in
patient outcomes between the two groups. In a trial with a
more vulnerable population (e.g. cancer patients) or with
serious adverse events, participants could potentially have
very different experiences which could affect their attitude
towards the method of feeding back trial results. They
might prefer a short leaflet that is plain and simple with
clear messages such as “what these results mean to you”
or “further steps you should take”. It might also be impor-
tant to present the findings separately for those who had a
positive result compared with those who have had nega-
tive results, with the latter requiring a more personalised
delivery of results through a telephone call or visit to the
clinic [18]. Indeed, it might be appropriate to guide the
participant back to their main care provider who can offer
the necessary clinical advice in the context of the trial
results. Our study also used a randomised trial design and
was evaluating the effectiveness of a diagnostic test. Parti-
cipants that have a different experience of research which
use alternative study designs (e.g. surveys, cohorts) or an
evaluation of different treatments might like the results of
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study might also have benefited from the involvement of
trial participants in the design and piloting of the leaflets
which has been recommended for future research [28]. In
addition to postal methods of feeding back results, other
communication methods have been suggested including
the telephone or a face-to-face consultation [6]. Using the
postal method is likely to be less time consuming and
costly than the additional salary required for a suitably
trained and knowledgeable person to spend time explain-
ing trial results to individual participants. In our study, it
only cost £105 and £252 to print the one-page and four-
page leaflets respectively and the cost of posting these
materials was estimated to be £150. The cost per trial par-
ticipant for sending out both leaflets was therefore £1.22.
Finally randomised trials are increasingly making use of
the internet and email to recruit participants, to maintain
contact during the trial, to deliver the intervention and to
collect data [29,30]. Participants could be asked when
enrolled into a trial whether an electronic method could
be used to feed back the results.
Conclusions
Serious consideration should be given about how and to
whom the results of the trial should be fed back to par-
ticipants as part of good research practice [2-4]. This is
important for sharing the results of the research to the
patients for which they contributed and might improve
their future care [8]. Participants in our trial did want to
receive feed back about the trial results and appear to
prefer the longer leaflet supported with graphs to pre-
sent study findings and more technical information. It is
possible that there could be a difference between males
and females as to how information should be communi-
cated to them and requires further research. Future
research should also assess the effect of participants’
preferences in different patient populations with more
significant differences in outcomes and the effect of
other modes of communicating trial findings on their
understanding of results. Finally feeding back the results
of trials to participants has the advantage of not only
underpinning good research practice, but also appeals to
participants’ altruistic motives [31,32] and sharing study
results might enhance their understanding of rando-
mised trials [33]. This could have the advantage of
improving recruitment and co-operation with data col-
lection and ultimately the evidence-base to improve
patient care.
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